|
F8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.24440466212172E-11 |
| Normal-vs-Stage2 |
2.235900E-04 |
| Normal-vs-Stage3 |
7.69080000000422E-05 |
| Normal-vs-Stage4 |
7.540400E-03 |
| Stage1-vs-Stage2 |
5.088600E-01 |
| Stage1-vs-Stage3 |
6.508200E-01 |
| Stage1-vs-Stage4 |
4.87809999949462E-07 |
| Stage2-vs-Stage3 |
3.692800E-01 |
| Stage2-vs-Stage4 |
2.176000E-03 |
| Stage3-vs-Stage4 |
3.103700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
7.699300E-03 |
| Normal-vs-Asian |
3.307200E-01 |
| Caucasian-vs-AfricanAmerican |
5.503200E-01 |
| Caucasian-vs-Asian |
2.212600E-01 |
| AfricanAmerican-vs-Asian |
6.421200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.06976666308856E-12 |
| Normal-vs-Female |
1.27850000031238E-07 |
| Male-vs-Female |
9.344000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.029800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.56309998067661E-10 |
| Normal-vs-Age(61-80Yrs) |
4.27799995428302E-09 |
| Normal-vs-Age(81-100Yrs) |
1.301930E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.709200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.138000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.344800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.717600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.346600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.773000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.227500E-02 |
| Normal-vs-Grade 2 |
3.95820043408435E-10 |
| Normal-vs-Grade 3 |
4.53189999971571E-08 |
| Normal-vs-Grade 4 |
1.502310E-02 |
| Grade 1-vs-Grade 2 |
8.103000E-01 |
| Grade 1-vs-Grade 3 |
5.675200E-01 |
| Grade 1-vs-Grade 4 |
2.016400E-01 |
| Grade 2-vs-Grade 3 |
4.084000E-01 |
| Grade 2-vs-Grade 4 |
5.043900E-02 |
| Grade 3-vs-Grade 4 |
2.348400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62503344114384E-12 |
| Normal-vs-ccB subtype |
1.56555999999419E-05 |
| ccA subtype-vs-ccB subtype |
4.774400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.53529996785807E-09 |
| Normal-vs-N1 |
5.302200E-01 |
| N0-vs-N1 |
9.25499999970825E-08 |
|
|
